Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
STAT Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress Yahoo Finance This pancreatic cancer treatment is on track for ‘one of the best drug launches of all time’ MarketWatch Rasonque sales drive up RevMed's…
The report was published on 05 de novembro de 2026 às 09:36 by STAT and is part of the Business coverage.
Quick answers
Who reported this story?
It was first reported by STAT on 05 de novembro de 2026 às 09:36.
What is the category?
It is filed under Business on Rio Warzone News.
